Clinical trial
2/2 D-Cycloserine Augmentation of CBT for Pediatric OCD
NCT01404208 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 2/2 D-Cycloserine Augmentation of CBT for Pediatric OCD
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2011
- Completion date
- December 31, 2016
- Enrollment
- 206 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.